This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

GENEVAX IL-12

Profectus Biosciences, Inc.

Drug Names(s): GENEVAX IL-12 pDNA adjuvant vaccine

Description: GENEVAX IL-12 is a proprietary formulation of a plasmid DNA vector that expresses the p40 and p35 subunits of the human cytokine Interleukin-12 plus the anesthetic bupivacaine. In addition to its anesthetic properties, bupivacaine has been shown to significantly stabilize and enhance the efficiency of DNA vaccines.


GENEVAX IL-12 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug